Merck’s Molnupiravir reduces hospitalisation risk in COVID patients, says study EP News Bureau Oct 2, 2021 If authorised, Molnupiravir could be the first oral anti-viral medicine for COVID-19
Remdesivir’s price must not be more than Rs 1400 per vial: Maha Health Minister Press Trust of India Apr 9, 2021 Tope said with a rapid rise in COVID-19 cases, the state may need 1.5 lakh Remdesivir injections daily which would require ramping…
Dexamethasone, low cost steroid drug can reduce COVID-19 mortality Reuters Jun 17, 2020 Hailing it is a ‘major breakthrough’, researchers claim that this medicine reduced death rates by around a third among the most…